TNFSF9 Antikörper (Biotin)
-
- Target Alle TNFSF9 Antikörper anzeigen
- TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TNFSF9 Antikörper ist konjugiert mit Biotin
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Spezifität
- Human TNFSF9 / CD137L
- Aufreinigung
- Caprylic acid and ammonium sulfate precipitation
- Immunogen
-
Recombinant human ATumor necrosis factor ligand superfamily member 9 protein.
Type of Immunogen: Recombinant protein - Isotyp
- IgG
- Top Product
- Discover our top product TNFSF9 Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.4, 0.03 % Proclin 300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid freeze-thaw cycles.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Target
- TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))
- Andere Bezeichnung
- TNFSF9 / CD137L (TNFSF9 Produkte)
- Synonyme
- TNFSF9 antikoerper, 4-1BB-L antikoerper, 4-1BBL antikoerper, AI848817 antikoerper, Cd137l antikoerper, Ly63l antikoerper, CD137L antikoerper, TNF superfamily member 9 antikoerper, tumor necrosis factor (ligand) superfamily, member 9 antikoerper, Tnfsf9 antikoerper, LOC476729 antikoerper, TNFSF9 antikoerper
- Hintergrund
-
Name/Gene ID: TNFSF9
Family: TNF
Synonyms: TNFSF9, 4-1BBL, 4-1BB ligand, 4-1BB-L, CD137L, Homolog of mouse 4-1BB-L, Receptor 4-1BB ligand - Gen-ID
- 8744
- Pathways
- Activated T Cell Proliferation, Cancer Immune Checkpoints
-